These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 22523317

  • 21. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J, Orden B, Bautista V, Cuevas O, Arroyo M, Martínez-Ruiz R, Pérez-Vázquez M, Alcaraz M, García-Cobos S, Campos J.
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [Abstract] [Full Text] [Related]

  • 22. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China.
    Tian GB, Wang HN, Zou LK, Tang JN, Zhao YW, Ye MY, Tang JY, Zhang Y, Zhang AY, Yang X, Xu CW, Fu YJ.
    Foodborne Pathog Dis; 2009 Apr; 6(3):297-304. PubMed ID: 19272004
    [Abstract] [Full Text] [Related]

  • 23. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.
    Dubois V, De Barbeyrac B, Rogues AM, Arpin C, Coulange L, Andre C, M'zali F, Megraud F, Quentin C.
    J Antimicrob Chemother; 2010 Jul; 65(7):1368-71. PubMed ID: 20466850
    [Abstract] [Full Text] [Related]

  • 24. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.
    Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH.
    J Clin Microbiol; 2008 Dec; 46(12):3900-5. PubMed ID: 18842941
    [Abstract] [Full Text] [Related]

  • 25. Emergence of CTX-M-2-producing Escherichia coli in diseased horses: evidence of genetic exchanges of bla(CTX-M-2) linked to ISCR1.
    Smet A, Boyen F, Flahou B, Doublet B, Praud K, Martens A, Butaye P, Cloeckaert A, Haesebrouck F.
    J Antimicrob Chemother; 2012 May; 67(5):1289-91. PubMed ID: 22328640
    [No Abstract] [Full Text] [Related]

  • 26. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway.
    Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, Sundsfjord A, Norwegian ESBL Study Group.
    APMIS; 2009 Jul; 117(7):526-36. PubMed ID: 19594493
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum beta-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay.
    Khan MA, Lemmens N, Riera E, Blonk T, Goedhart J, Van Belkum A, Goessens W, Hays JP, Van Westreenen M.
    J Antimicrob Chemother; 2009 Dec; 64(6):1330-2. PubMed ID: 19854861
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.
    Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S.
    J Antimicrob Chemother; 2010 Apr; 65(4):651-60. PubMed ID: 20118165
    [Abstract] [Full Text] [Related]

  • 32. Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe.
    Pomba C, López-Cerero L, Bellido M, Serrano L, Belas A, Couto N, Cavaco-Silva P, Rodríguez-Baño J, Pascual A.
    J Antimicrob Chemother; 2014 Jan; 69(1):271-3. PubMed ID: 24022069
    [No Abstract] [Full Text] [Related]

  • 33. ESBL- and plasmidic class C beta-lactamase-producing E. coli strains isolated from poultry, pig and rabbit farms.
    Blanc V, Mesa R, Saco M, Lavilla S, Prats G, Miró E, Navarro F, Cortés P, Llagostera M.
    Vet Microbiol; 2006 Dec 20; 118(3-4):299-304. PubMed ID: 16973308
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Presence of extended-spectrum β-lactamase-producing Escherichia coli in wild geese.
    Garmyn A, Haesebrouck F, Hellebuyck T, Smet A, Pasmans F, Butaye P, Martel A.
    J Antimicrob Chemother; 2011 Jul 20; 66(7):1643-4. PubMed ID: 21467083
    [No Abstract] [Full Text] [Related]

  • 39. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.
    Peirano G, van Greune CH, Pitout JD.
    Diagn Microbiol Infect Dis; 2011 Apr 20; 69(4):449-53. PubMed ID: 21396544
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.